Education
About Us
Working with TipRanks
Follow Us
Sinco Pharmaceuticals Holdings Ltd. (HK:6833)
:6833
RESEARCH TOOLSreports
Total Valuation
Sinco Pharmaceuticals Holdings Ltd. has a market cap or net worth of HK$386.25M. The enterprise value is HK$338.65M.
Market CapHK$386.25M
Enterprise ValueHK$338.65M
Share Statistics
Sinco Pharmaceuticals Holdings Ltd. has 2,032,890,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,032,890,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sinco Pharmaceuticals Holdings Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.98%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.98%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee9.70M
Profits Per Employee339.93K
Employee Count291
Asset Turnover1.41
Inventory Turnover7.16
Valuation Ratios
The current PE Ratio of Sinco Pharmaceuticals Holdings Ltd. is 9.25. Sinco Pharmaceuticals Holdings Ltd.’s PEG ratio is -0.12.
PE Ratio9.25
PS Ratio0.00
PB Ratio0.79
Price to Fair Value0.59
Price to FCF21.23
Price to Operating Cash Flow6.33
PEG Ratio-0.12
Income Statement
In the last 12 months, Sinco Pharmaceuticals Holdings Ltd. had revenue of 2.82B and earned 42.05M in profits. Earnings per share was 0.02.
Revenue2.82B
Gross Profit299.94M
Operating Income94.94M
Pretax Income98.92M
Net Income42.05M
EBITDA132.60M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was -232.88M and capital expenditures -35.17M, giving a free cash flow of -268.05M billion.
Operating Cash Flow-232.88M
Free Cash Flow-268.05M
Free Cash Flow per Share-0.13
Dividends & Yields
Sinco Pharmaceuticals Holdings Ltd. pays an annual dividend of HK$0.002, resulting in a dividend yield of 1.06%
Dividend Per ShareHK$0.002
Dividend Yield1.06%
Payout Ratio8.70%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.08
52-Week Price Change-20.83%
50-Day Moving Average0.18
200-Day Moving Average0.20
Relative Strength Index (RSI)55.11
Average Volume (3m)120.20K
Important Dates
Sinco Pharmaceuticals Holdings Ltd. upcoming earnings date is Aug 27, 2025, TBA (Confirmed).
Last Earnings DateMar 28, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateMay 19, 2025
Financial Position
Sinco Pharmaceuticals Holdings Ltd. as a current ratio of 1.14, with Debt / Equity ratio of 31.87%
Current Ratio1.14
Quick Ratio0.87
Debt to Market Cap0.88
Net Debt to EBITDA0.32
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sinco Pharmaceuticals Holdings Ltd. has paid 56.88M in taxes.
Income Tax56.88M
Effective Tax Rate0.57
Enterprise Valuation
Sinco Pharmaceuticals Holdings Ltd. EV to EBITDA ratio is 3.25, with an EV/FCF ratio of -1.61.
EV to Sales0.15
EV to EBITDA3.25
EV to Free Cash Flow-1.61
EV to Operating Cash Flow-1.85
Balance Sheet
Sinco Pharmaceuticals Holdings Ltd. has HK$308.32M in cash and marketable securities with ¥350.54M in debt, giving a net cash position of HK$42.22M billion.
Cash & Marketable SecuritiesHK$308.32M
Total Debt¥350.54M
Net CashHK$42.22M
Net Cash Per ShareHK$0.02
Tangible Book Value Per ShareHK$0.26
Margins
Gross margin is 13.47%, with operating margin of 3.37%, and net profit margin of 1.49%.
Gross Margin13.47%
Operating Margin3.37%
Pretax Margin3.51%
Net Profit Margin1.49%
EBITDA Margin4.70%
EBIT Margin4.04%
Analyst Forecast
The average price target for Sinco Pharmaceuticals Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.27%
EPS Growth Forecast-2.61%